Role of RAS inhibition in the regulation of Cu/Zn-SOD in the cardiac and peripheral arterial beds in humans

Clinical Pharmacology and Therapeutics

Volumn 87, Issue 6, 2010, Pages 686-692

  Kuster, G M ^a   Nietlispach, F ^a   Kiowski, W ^b   Schindler, R ^a   Bernheim, A ^a   Schuetz, P ^a   Mueller, B ^c   Morgenthaler, N G ^d   Ruter F ^a   Riesen, W ^c   Rickli, H ^c   Brunner La Rocca, H P ^a,e  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b KLINIK IM PARK   (Switzerland)

^c Kantonsspital Aarau ^*  (Switzerland)

^d BRAHMS AG   (Germany)

^e MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTICOAGULANT AGENT; BENAZEPRIL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; COPPER ZINC SUPEROXIDE DISMUTASE; DIGOXIN; LOW DENSITY LIPOPROTEIN; NITRATE; VALSARTAN;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY SINUS BLOOD FLOW; DOUBLE BLIND PROCEDURE; FEMALE; HEART FAILURE; HEART HEMODYNAMICS; HUMAN; MALE; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; UNSPECIFIED SIDE EFFECT;

ADULT; AGED; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BENZAZEPINES; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HEART FAILURE; HEMODYNAMICS; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; OXIDATIVE STRESS; RENIN-ANGIOTENSIN SYSTEM; SUPEROXIDE DISMUTASE; TETRAZOLES; VALINE;

EID: 77952586057     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2010.36     Document Type: Article

References (38)

1. Belch, J.J., Bridges, A.B., Scott, N. & Chopra, M. Oxygen free radicals and congestive heart failure. Br. Heart J. 65, 245-248 (1991).
2. Dhalla, A.K., Hill, M.F. & Singal, P.K. Role of oxidative stress in transition of hypertrophy to heart failure. J. Am. Coll. Cardiol. 28, 506-514 (1996).
3. Ide, T. et al. Direct evidence for increased hydroxyl radicals originating from superoxide in the failing myocardium. Circ. Res. 86, 152-157 (2000).
4. Ide, T. et al. Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium. Circ. Res. 85, 357-363 (1999).
5. Landmesser, U. et al. Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine-oxidase and extracellular superoxide dismutase. Circulation 106, 3073-3078 (2002).
6. McMurray, J., Chopra, M., Abdullah, I., Smith, W.E. & Dargie, H.J. Evidence of oxidative stress in chronic heart failure in humans. Eur. Heart J. 14, 1493-1498 (1993).
7. Puurunen, M. et al. Antibody against oxidized low-density lipoprotein predicting myocardial infarction. Arch. Intern. Med. 154, 2605-2609 (1994).
8. Bäumer, A.T., Flesch, M., Wang, X., Shen, Q., Feuerstein, G.Z. & Böhm, M. Antioxidative enzymes in human hearts with idiopathic dilated cardiomyopathy. J. Mol. Cell. Cardiol. 32, 121-130 (2000).
9. Dhalla, A.K. & Singal, P.K. Antioxidant changes in hypertrophied and failing guinea pig hearts. Am. J. Physiol. 266, H1280-H1285 (1994).
10. Dieterich, S., Bieligk, U., Beulich, K., Hasenfuss, G. & Prestle, J. Gene expression of antioxidative enzymes in the human heart: increased expression of catalase in the end-stage failing heart. Circulation 101, 33-39 (2000).
11. Sam, F. et al. Increased reactive oxygen species production and functional alterations in antioxidant enzymes in human failing myocardium. J. Card. Fail. 11, 473-480 (2005).
12. Braunwald, E. Biomarkers in heart failure. N. Engl. J. Med. 358, 2148-2159 (2008).
13. Mallat, Z., Philip, I., Lebret, M., Chatel, D., Maclouf, J. & Tedgui, A. Elevated levels of 8-iso-prostaglandin F2alpha in pericardial fuid of patients with heart failure: a potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure. Circulation 97, 1536-1539 (1998).
14. Sawyer, D.B., Siwik, D.A., Xiao, L., Pimentel, D.R., Singh, K. & Colucci, W.S. Role of oxidative stress in myocardial hypertrophy and failure. J. Mol. Cell. Cardiol. 34, 379-388 (2002).
15. Sorescu, D. & Griendling, K.K. Reactive oxygen species, mitochondria, and NAD(P)H oxidases in the development and progression of heart failure. Congest. Heart Fail. 8, 132-140 (2002).
16. Hornig, B. et al. Comparative efect of ace inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: role of superoxide dismutase. Circulation 103, 799-805 (2001).
17. de Cavanagh, E.M., Inserra, F., Toblli, J., Stella, I., Fraga, C.G. & Ferder, L. Enalapril attenuates oxidative stress in diabetic rats. Hypertension 38, 1130-1136 (2001).
18. Pizzi, C., Manfrini, O., Fontana, F. & Bugiardini, R. Angiotensin-converting enzyme inhibitors and 3-hydroxy-3-methylglutaryl coenzyme A reductase in cardiac Syndrome X: role of superoxide dismutase activity. Circulation 109, 53-58 (2004).
19. Tsutamoto, T. et al. Relationship between tumor necrosis factor-alpha production and oxidative stress in the failing hearts of patients with dilated cardiomyopathy. J. Am. Coll. Cardiol. 37, 2086-2092 (2001).
20. George, J., Wexler, D., Roth, A., Barak, T., Sheps, D. & Keren, G. Usefulness of anti-oxidized LDL antibody determination for assessment of clinical control in patients with heart failure. Eur. J. Heart Fail. 8, 58-62 (2006).
21. Tsutsui, T. et al. Plasma oxidized low-density lipoprotein as a prognostic predictor in patients with chronic congestive heart failure. J. Am. Coll. Cardiol. 39, 957-962 (2002).
22. Lehtimäki, T. et al. Autoantibodies against oxidized low density lipoprotein in patients with angiographically verifed coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 19, 23-27 (1999).
23. Ekelund, U.E. et al. Intravenous allopurinol decreases myocardial oxygen consumption and increases mechanical efciency in dogs with pacing-induced heart failure. Circ. Res. 85, 437-445 (1999).
24. Young, I.S. & McEneny, J. Lipoprotein oxidation and atherosclerosis. Biochem. Soc. Trans. 29, 358-362 (2001).
25. Tanaka, M. et al. Angiotensin II type 1 receptor antagonist and angiotensin-converting enzyme inhibitor altered the activation of Cu/Zn-containing superoxide dismutase in the heart of stroke-prone spontaneously hypertensive rats. Hypertens. Res. 28, 67-77 (2005).
26. Beckman, J.S. & Koppenol, W.H. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am. J. Physiol. 271, C1424-C1437 (1996).
27. Groeger, G., Quiney, C. & Cotter, T.G. Hydrogen peroxide as a cell-survival signaling molecule. Antioxid. Redox Signal. 11, 2655-2671 (2009).
28. Henderson, B.C., Tyagi, N., Ovechkin, A., Kartha, G.K., Moshal, K.S. & Tyagi, S.C. Oxidative remodeling in pressure overload induced chronic heart failure. Eur. J. Heart Fail. 9, 450-457 (2007).
29. Khaper, N. & Singal, P.K. Efects of afterload-reducing drugs on pathogenesis of antioxidant changes and congestive heart failure in rats. J. Am. Coll. Cardiol. 29, 856-861 (1997).
30. Cheng, W. et al. Stretch-induced programmed myocyte cell death. J. Clin. Invest. 96, 2247-2259 (1995).
31. Dimmeler, S., Hermann, C., Galle, J. & Zeiher, A.M. Upregulation of superoxide dismutase and nitric oxide synthase mediates the apoptosis- suppressive efects of shear stress on endothelial cells. Arterioscler. Thromb. Vasc. Biol. 19, 656-664 (1999).
32. Inoue, N., Ramasamy, S., Fukai, T., Nerem, R.M. & Harrison, D.G. Shear stress modulates expression of Cu/Zn superoxide dismutase in human aortic endothelial cells. Circ. Res. 79, 32-37 (1996).
33. Pech, V., Sikka, S.C., Sindhu, R.K., Vaziri, N.D. & Majid, D.S. Oxidant stress and blood pressure responses to angiotensin II administration in rats fed varying salt diets. Am. J. Hypertens. 19, 534-540 (2006).
34. Komine, N., Khang, S., Wead, L.M., Blantz, R.C. & Gabbai, F.B. Efect of combining an ACE inhibitor and an angiotensin II receptor blocker on plasma and kidney tissue angiotensin II levels. Am. J. Kidney Dis. 39, 159-164 (2002).
35. Brunner-La Rocca, H.P., Esler, M.D., Jennings, G.L. & Kaye, D.M. Efect of cardiac sympathetic nervous activity on mode of death in congestive heart failure. Eur Heart J 22, 1136-1143 (2001).
36. Holvoet, P. et al. Analytical performance and diagnostic accuracy of immunometric assays for the measurement of circulating oxidized LDL. Clin. Chem. 52, 760-764 (2006).
37. Porstmann, T. et al. Production and characterization of monoclonal antibodies against human Cu/Zn superoxide dismutase and the establishment of a super-rapid enzyme-linked immunosorbent assay (SURALISA). J. Immunol. Methods 127, 1-10 (1990).
38. Papassotiriou, J., Morgenthaler, N.G., Struck, J., Alonso, C. & Bergmann, A. Immunoluminometric assay for measurement of the C-terminal endothelin-1 precursor fragment in human plasma. Clin. Chem. 52, 1144-1151 (2006).